DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 234 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,078 | +14.3% | 750 | 0.0% | 0.01% | +28.6% |
| Q2 2023 | $9,690 | +31.7% | 750 | 0.0% | 0.01% | +16.7% |
| Q1 2023 | $7,358 | -7.8% | 750 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $7,980 | -0.2% | 750 | 0.0% | 0.01% | -14.3% |
| Q3 2022 | $8,000 | -11.1% | 750 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $9,000 | +12.5% | 750 | 0.0% | 0.01% | +40.0% |
| Q1 2022 | $8,000 | -27.3% | 750 | 0.0% | 0.01% | -28.6% |
| Q4 2021 | $11,000 | -21.4% | 750 | 0.0% | 0.01% | -30.0% |
| Q3 2021 | $14,000 | +100.0% | 750 | 0.0% | 0.01% | +100.0% |
| Q2 2021 | $7,000 | 0.0% | 750 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $7,000 | +133.3% | 750 | 0.0% | 0.01% | +100.0% |
| Q4 2020 | $3,000 | 0.0% | 750 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $3,000 | -57.1% | 750 | 0.0% | 0.00% | -62.5% |
| Q2 2020 | $7,000 | +250.0% | 750 | 0.0% | 0.01% | +300.0% |
| Q1 2020 | $2,000 | -50.0% | 750 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $4,000 | – | 750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |